China Gold International Resources (2099)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 201.60 |
|---|---|
| 52-week range | 110.00 – 280.60 |
| Return, 1 month / 3 months | −18.3% / +27.8% |
| Return, 1 year / 3 years | +32.0% / +444.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 65.2% |
| Worst drawdown (1 year) | -49.9% |
| Average daily value traded | 537.12M HKD |
| Dividend yield | 1.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Gold International Resources is a mining company that produces gold and copper concentrates. It operates the Chang Shan Hao gold mine in Inner Mongolia and the Jiama copper-gold polymetallic mine in Tibet, where ore is mined and processed into concentrate for sale to smelters and metal traders. The company is based in Hong Kong and is controlled by a Chinese state-owned gold mining group.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 2099, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Gold International Resources (2099) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 201.60 on 20 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 428 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 32.0% and over the last three months it rose 27.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.2% | ||
| From 52-week high | -27.1% | ||
| Momentum | 86 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 27.8% | ||
| 6-month return | 10.2% | ||
| 12-month return, skipping the last month | 61.6% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 65.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.9% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 537.12M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 18 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.4% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.8% |
|---|---|
| 1 month | −18.3% |
| 3 months | +27.8% |
| 6 months | +10.2% |
| 1 year | +32.0% |
| 3 years | +444.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 234.54 / 184.59 |
|---|---|
| Golden / death cross (60 days) | Golden, 40 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Apr 2026 | HKD 2.7414 |
| 22 Apr 2025 | HKD 0.2327 |
| 19 Apr 2023 | HKD 2.9044 |
| 19 Apr 2022 | HKD 1.9605 |
| 19 Apr 2021 | HKD 0.9319 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.